Cigna (CI) EBIT (2017 - 2026)

Cigna's EBIT history runs 10 years deep, the most recent figure standing at $202.0 million for Q1 2026.

• In Q1 2026, EBIT fell 15.13% year-over-year to $202.0 million; the TTM figure through Mar 2026 stood at $3.0 billion (down 43.18% YoY), while the FY2025 annual figure was $9.2 billion, down 2.3% from the prior year.
• EBIT came in at $202.0 million for Q1 2026 at Cigna, down from $2.3 billion in the prior quarter.
• In the past five years, EBIT ranged from a high of $7.7 billion in Q4 2023 to a low of $202.0 million in Q1 2026.
• A 5-year average of $1.4 billion and a median of $321.0 million in 2023 frame the typical range for EBIT.
• Across the five-year window, EBIT jumped 714.44% in 2024 and slumped 90.95% in 2025, its largest moves.
• Cigna's EBIT stood at $1.7 billion in 2022, then surged by 337.96% to $7.7 billion in 2023, then slumped by 71.63% to $2.2 billion in 2024, then grew by 7.92% to $2.3 billion in 2025, then plunged by 91.39% to $202.0 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $202.0 million, $2.3 billion, and $233.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison